Cite
APA Citation
Shebl, A., Durn, B. L., Bril, V., Merkies, I. S., Geloven, N., Hartung, H., Lewis, R. A., Sobue, G., Lawo, J., Cornblath, D. R., Mielke, O., van Schaik, I. N., & , (n.d.). 17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study. Clinical neurophysiology, 131(3), e7–e8. http://access.bl.uk/ark:/81055/vdc_100099964386.0x000020